Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEKTAR THERAPEUTICS Director's Dealing 2014

Sep 25, 2014

32134_dirs_2014-09-25_e440189f-3b42-47d5-a216-9bd9aaf77c79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2014-09-23

Reporting Person: WINGER DENNIS L (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-09-23 Stock Option $12.70 A 45000 Acquired 2022-09-22 Common Stock (45000) Direct

Footnotes

F1: This stock option vests in equal monthly installments over a 1 year period beginning on September 30, 2014 based on the Reporting Person's continuous service to the Issuer.